Thirumalai Chemicals DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.86×0.83×1.13×1.12×0.69×
2.53×1.63×3.32×2.84×0.99×
−3.8%−7.1%−0.6%−0.6%6.1%
0.41×0.41×0.58×0.73×1.01×
3.03×3.03×3.29×2.90×1.98×
−10.3%−12.0%−4.3%−3.9%8.4%
−12.4%−12.4%−4.0%−3.3%7.9%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

TIRUMALCHM₹119.75

Thirumalai Chemicals Limited

· Chemicals
₹ CrorePeersPAUSHAKLTDDEEPAKNTRFACTCLEANCAMLINFINEVIDHIINGBAYERCROPJUBLINGREAMcap ₹1,444 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.691.121.130.830.86
Interest Burden (Pretax/EBIT) ×0.992.843.321.632.53
EBIT Margin %6.12-0.58-0.60-7.12-3.80
Asset Turnover ×1.010.730.580.410.41
Financial Leverage (Assets/Equity) ×1.982.903.293.033.03
ROE (5-step product, year-end total equity) %8.43-3.94-4.30-12.02-10.28
ROE (owners' profit / average owners' equity) %7.89-3.32-4.01-12.35-12.35
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.